Objective To determine the disease-causing mutation in a Chinese family with retinitis pigmentosa (RP) and to characterize the clinical phenotypes. Methods Genomic DNA was extracted from each blood sample. We developed a panel for targeted exome sequencing (TES) by selecting 201 inherited retinal dystrophy genes. The proband was performed with TES and comprehensive genetic analyses. Results Ophthalmic examination of the proband showed a typical RP phenotype. After TES and comprehensive genetic analyses, we identified two compound heterozygous mutations (c.6416G>A, p.C2139Y; c.8012T>A, p.L2671X) in the EYS gene, which was responsible for causing RP. Conclusion In this study, targeted exome sequencing revealed pathogenic mutations in EYS in a Chinese family with RP.
金卡露,章峥嵘,王毅. 应用新一代目标区域捕获测序揭示视网膜色素变性患者的EYS基因突变[J]. 中华眼视光学与视觉科学杂志, 2016, 18(1): 25-28.
Jin Kalu*,Zhang Zhengrong,Wang Yi. Targeted exome sequencing identifies EYS mutations in a family with retinitis pigmentosa. Chinese Journal of Optometry Ophthalmology and Visual science, 2016, 18(1): 25-28. DOI: DOI:10.3760/cma.j.issn.1674-845X.2016.01.006
Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa[J]. Lancet,2006,368(9549):1795-1809. DOI:10.1016/S0140-6736(06)69740-7.
[2]
Haim M. Retinitis pigmentosa: problems associated with genetic classification[J]. Clin Genet,1993,44(2):62-70. DOI:10.1111/j.1399-0004.1993.tb03848.x.
[3]
Huang XF, Huang F, Wu KC, et al. Genotype-phenotype correlation and mutation spectrum in a large cohort of patients with inherited retinal dystrophy revealed by next-generation sequencing[J]. Genet Med,2015,17(4):271-278. DOI:10.1038/gim.2014.138.
[4]
Shendure J. Next-generation human genetics[J]. Genome Biol, 2011,12(9):408. DOI:10.1186/gb-2011-12-9-408.
[5]
Simpson DA, Clark GR, Alexander S, et al. Molecular diagnosis for heterogeneous genetic diseases with targeted high-throughput DNA sequencing applied to retinitis pigmentosa[J]. J Med Genet,2011,48(3):145-151. DOI:10.1136/jmg.2010.083568.
[6]
Xing DJ, Zhang HX, Huang N, et al. Comprehensive molecular diagnosis of Bardet-Biedl syndrome by high-throughput targeted exome sequencing[J]. PLoS One,2014,9(3):e90599. DOI:10.1371/journal.pone.0090599.
Neveling K, Collin RW, Gilissen C, et al. Next-generation genetic testing for retinitis pigmentosa[J]. Hum Mutat,2012,33(6):963-972. DOI:10.1002/humu.22045.
[9]
Abu-Safieh L, Alrashed M, Anazi S, et al. Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes[J]. Genome Res,2013,23(2):236-247. DOI:10.1101/gr.144105.112.
[10]
Huang XF, Wu J, Lv JN, et al. Identification of false-negative mutations missed by next-generation sequencing in retinitis pigmentosa patients: a complementary approach to clinical genetic diagnostic testing[J]. Genet Med,2015,17(4):307-311. DOI:10.1038/gim.2014.193.
[11]
Chen X, Liu X, Sheng X, et al. Targeted next-generation sequencing reveals novel EYS mutations in Chinese families with autosomal recessive retinitis pigmentosa[J]. Sci Rep,2015, 5:8927. DOI:10.1038/srep08927.
[12]
Abd El-Aziz MM, Barragan I, O′Driscoll CA, et al. EYS, encoding an ortholog of Drosophila spacemaker, is mutated in autosomal recessive retinitis pigmentosa[J]. Nat Genet,2008,40(11):1285-1287. DOI:10.1038/ng.241.
[13]
Collin RW, Littink KW, Klevering BJ, et al. Identification of a 2 Mb human ortholog of Drosophila eyes shut/spacemaker that is mutated in patients with retinitis pigmentosa[J]. Am J Hum Genet,2008,83(5):594-603. DOI:10.1016/j.ajhg.2008.10.014.